Cardiologist in Oxon Hill, MD

The National Institutes of Health will require all grants submitted on or after Jan. 25, 2023 to include a Data Management and Sharing Policy. As part of this policy, all new NIH funding mechanisms that produce research data will need to document a two page Data Management and Sharing Plan , which will be considered a term and condition of the award. All Duke Health team members will receive information about and a link to the 2022 CulturePulse survey on Wednesday, Nov. 2. Questions will cover your sense of belonging, safety, and well-being, as well as the strength of your teams and management.
Duke joined the AMPATH consortium in 2009 with support from a National Heart, Lung, and Blood Institute grant to create a cardiovascular and pulmonary disease Center of Excellence. The Cardiovascular Center of Excellence partnership has been a joint effort led by the Hubert-Yeargan Center for Global Health , the Duke Clinical Research Institute and Duke Heart, with initial leadership from Duke faculty members Eric Velazquez and Gerald Bloomfield. Arges and others are working to raise funds to ensure that all 70 patients currently enrolled in the clinical trial can receive compassionate use of stem cells upon completion of Phase 2.

On behalf of the entire Duke Heart leadership team, we wish you and your loved ones a happy Thanksgiving. During this time of reflection on our many personal blessings, we also give fibroids treatment near me thanks for the incredible team we have here in Duke Heart. Together, we have persevered through some big challenges over the last several years, and also accomplished a great deal.

Trained in computer science, medicine, biostatistics, and research, he brings over 20 years of experience in patient care, outcomes research and trials, data science and artificial intelligence, medical device regulation, and the creation and commercialization of digital health products. Dr. Singh's is currently the national & global principal investigator on 7 ongoing multi-center clinical trials in device therapy, sensor strategies and artificial intelligence for heart failure and atrial fibrillation. Much of his current efforts are focused on healthcare redesign, digital health, and medical device innovations. At Stanford, he was the Co-Founder and Director of the Stanford Center for Digital Health, where he led a large multidisciplinary research program in heart rhythm disorders, real-world evidence, clinical trials, and digital health.
Dr. Poole is a passionate supporter for Women in EP, participating and/or leading several Women in EP organizations. She champions enhanced enrollment of women and racial/ethnic minorities into clinical trials, having co-authored multiple publications. Dr. Murphy is the Chief Research Information Officer at Mass General Brigham, is a Professor of Neurology and Biomedical Informatics at Harvard Medical School and serves as Co-Director of the Center for Innovation in Digital Healthcare at the Massachusetts General Hospital.

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network. National Harbor is a 7.3M+ SF, mixed-use waterfront development along the Potomac River. The area includes  the Gaylord National Resort and Convention Center, hundreds of residential units, office spaces, popular shops and restaurants, and MGM Grand Resort and Casino.
Ray’s broad industry experience as a registered nurse, pharmacy manager, and cardiac device clinical specialist, as well as her hands-on sales and technical support for cardiovascular devices in the field, has prepared her to lead PaceMate™ with diligence and excellence. Dr. McManus serves as Chief of the Section of Connected Cardiovascular Healthcare and Director of the Anticoagulation Service and Atrial Fibrillation Treatment Program at UMMH. He  has led successful multi-site observational cohort studies (e.g., SAGE-AF) and clinical trials using point-of-care technologies (e.g., VITAL-AF, PULSEWATCH). As head of Global Business Marketing for Philips Ambulatory, Monitoring and Diagnostics, Jennifer Lavelle brings over 20 years of healthcare expertise to drive the transformation of care to become more decentralized and virtual by connecting data across the patient ecosystem. Shifting care from in the hospital to anywhere, episodic to continuous, reactive to proactive, condition specific to holistic.
After a career in surgical robotics and minimally invasive surgical procedures, he co-founded biocynetic™ in 2015, a software company aimed at  eliminating the burden of gathering and analyzing disparate data sources to treat AFib, heart failure, and other types of chronic diseases. Dr. Hernandez has research interests in improving cardiovascular health and accelerating clinical evidence through outcomes research, clinical trials, comparative effectiveness and health policy. He had led multiple large-scale patient-centered research programs, registries and clinical trials aimed at improving health across multiple conditions such as NIH's Health System Collaboratory and PCORI's PCORnet resulting in more than 700 peer-reviewed publications. Adrian Hernandez, MD, MHS, is Executive Director, Duke Clinical Research Institute, and Vice Dean of the Duke University School of Medicine.

Paul has interacted with thousands of medical technology startups as part of MedTech Innovator's rigorous review process to identify the most promising early-stage companies in the world. 509 companies are now in MedTech Innovator's portfolio, collectively bringing 155 products to market with a combined total of over $4.6B in follow-on funding. Prior to joining Rhythm, Thompson spent 15 years in the CRM industry working at Boston Scientific and BIOTRONIK in a variety of roles from product management to sales leadership.
She served as Chief Medical Officer at DRH for three years before beginning her current role as Duke University Hospital Chief Medical Officer in 2012. Lisa will join the Palliative Care Fellow class in July and so will continue her time with our Duke family. For those who may not know, Lisa began her career at Duke as an Intern and then a Resident in General Surgery in 1994.

We kick off our coverage this weekend with two of our late-breaking clinical trial presentations and close out with two award winners. It is hoped that faculty, students, and alumni will find Duke Capital Partners to be an exciting new way to engage with the university and its entrepreneurial community. Duke Capital Partners is the early-stage venture investing arm of Duke University, helping to connect Duke alumni investors with Duke-affiliated early-stage companies.
The information contained in this website is only for general information purposes. Any reliance you place on such information is therefore strictly at your own risk. Use of this website constitutes acceptance of the Terms of Service and Privacy Policy. Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease.